Stocks & ETFs to Buy

The key to finding a winning investment involves a degree of far-sightedness. You need to anticipate what a company’s financial results may look like 12-18 months from now, even as Wall Street analysts base their projections on the next quarter’s results. The… Read More

Important price levels on stocks aren’t perfect. Stocks can find support and/or resistance anywhere and at any price. However, when writing these articles, I highlight only the levels that appear MORE important than others. Although anything can happen between, above or below these levels, it is at the important ones… Read More

Owens Corning Inc. is a producer of glass fiber reinforcements and other materials for composites and of residential and commercial building materials. The Company’s products range from glass fiber used to reinforce composite materials for transportation, electronics, marine, infrastructure, wind-energy and other markets to insulation and roofing for residential, commercial… Read More

  Trading in the stock market can sometimes be complicated. It can also be confusing and challenging to know what trade to make and when to make it. However, there are those trading opportunities that are clearer and more obvious. Usually, the… Read More

Before the global economic downturn of 2008, a clear investing theme had emerged. Rising incomes across the world were leading to richer diets and triggering a boom for all kinds of stocks that helped farmers be more productive. This emerging trend helped enrich shareholders of Mosaic (NYSE:… Read More

Autodesk, Inc. is a design software and services company. Autodesk serves customers in the architecture, engineering and construction; manufacturing, and digital media and entertainment industries. It operates in four segments: Platform Solutions and Emerging Business, Architecture, Engineering and Construction, Manufacturing and Media and Entertainment. Its PSEB, AEC and MFG segments… Read More

The buyout frenzy that has gripped the pharmaceutical sector during the first two weeks of 2012 will more than likely continue. A long list of expiring patents and plenty of available cash are prompting large-cap pharmaceutical companies to seriously consider takeover opportunities in small-cap… Read More

  The buyout frenzy that has gripped the pharmaceutical sector during the first two weeks of 2012 will more than likely continue. A long list of expiring patents and plenty of available cash are prompting large-cap pharmaceutical companies to seriously consider takeover opportunities in… Read More